<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190226042845N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-04-21</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of acupressure on the onset of labor pain and its outcome</public_title>
      <acronym></acronym>
      <scientific_title>The effect of Auriculotherapy on cervical ripening, initition and outcome of labor in term primiparous women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/38691</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Researchers referred to counseling centers, midwifery and health centers Society of Medical Sciences Qom after introducing his plan, sufficient information on the research, such as research, study objectives, criteria for inclusion and exclusion criteria, how to how to conduct the study in pregnant women explained. Individuals willing to participate in the research and have criteria for entering the study are referred to the researcher and are informed by the informed consent and informed by a continuous and available sampling method.The samples were then randomly assigned (Permuted-Block Randomization) to two intervention and placebo groups as follows.
 That all possibilities for placement of the letters A and B will be considered in four blocks that make up a total of 6 modes. The 6 modes are numbered 1 to 6 and the number of 4 blocks required will be determined based on the number of sample cases. Then the required number of blocks, random number based on random numbers table will burst row, the top 6 numbers will not be considered. Finally, based on the order of the numbers extracted from the table, the blocks for each number will be listed, respectively, and when each instance is entered into the study, each person will take a specific word in order. For example, in the order of (AABB / AABB), the 5th person will be in Group B.Randomly, half the people of each block are placed in one group and the other half in the other group. In this study, we want to place 90 people in two groups of 45 patients in the field of auriculotherapy and placebo, Blinding description: A placebo group has been identified to achieve the goal of blindness.
In the placebo group, the procedure will be performed in such a way that the outer ear is cleansed ,Then several points from the same points in the intervention group that are effective for induction of childbirth are artificially  Massage with a pointer machine, so that no stimulation is performed.Then on the 3rd point of the left ear and on the 3rd point of the right ear, there is a seed placed without vakaria.The pregnant mother is told not to press the points.The placebo group 72 hours after vaginal examination done to determine the Bishop score, also uterine contractions and fetal heart rate also examined. The placebo group is also evaluated from the time of admission to the completion of the delivery stages.</study_design>
      <phase>N/A</phase>
      <hc_freetext>cervical ripening and labor initiation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: We randomly place 70 regnant women in the intervention and placebo groups. For each individual intervention group explained that  auriculotherapy  from 39 weeks to 40 weeks of pregnancy once done. If the cervix is unprepared and the labor pains do not begin 72 hours after the intervention, auriculotherapy is performed again. In the intervention group, before auriculotherapy to determine the Bishop score, vaginal exam as well as uterine contractions and fetal heart checked. For the preparation of cervix and the onset of  labour, 11 points are stimulated: Shen Men, master shoulder , thalamic, Hypothalamus, prostaglandin, anterior pituitary, posterior pituitary, endocrine, (2) uterine, lumbar and lung. After disinfection of the ear with 75% alcohol and one minute of general massage for relaxation, electrical stimulation was performed with a Pointer Excel 2 (Made in China) device with a frequency of 2–4 Hz and a current intensity of 2–4 mA, each point is stimulated by the researcher for 15 seconds. . Finally, 5 points of left ear including endocrine, posterior pituitary, prostaglandin and uterus (2 points) and 5 points of right ear including Shen Men ,thalamic, master shoulder ,lung, lumbar are placed one vacaria seed. The mother is instructed to push each point up to 72 hours every hour for 1 minute. Seed pressure should be enough power to cause pain and irritation of the outer ear.They may also experience different sensations when seed  pressure, such as numbness, swelling, mild pain or heat. It should be noted that during sleep and rest for 8 hours do not need to squeeze. To prevent forgetfulness, the researcher remembers pressing the points by phone, asking for possible problems and complications. Intervention 2: Placebo group: The placebo group will consist of 35 pregnant women who are eligible for the study. In this group, the outer ear is cleaned with 75% alcohol and then several points from the same points in the intervention group are massaged with the silent machine so that the stimulation is not triggered. It is then placed on the 3 points of the left ear including the thalamic, Shen Men, lung and the 3 points of the right ear including the posterior pituitary, prostaglandin and the uterus of a seed without vakaria. The pregnant mother is told not to push the points at all.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as information about the original outcome or the like, can be shared

When:
Start of access period 6 months after printing results

To whom:
Data can be obtained by researchers and people who are in treatment.

Conditions:
Data can be obtained by researchers and people who are in treatment.

Where to obtain:
z.mozafarirad.midwif@gmail.com

How to obtain:
z.mozafarirad.midwif@gmail.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zeynab Mozafari Rad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>College of Nursing and Midwifery, Tehran University of Medical Sciences, Tohid Square, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6692 7171</telephone>
        <email>z.mozafarirad.midwif@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zohreh Khakbazan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Tehran University of Medical Sciences, Tohid Square, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6692 7171</telephone>
        <email>khakbaza@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: All pregnant women with gestational age of 39 weeks to 40 weeks
Primiparous
Age 18-35 Years
Pregnancy is low risk (Lack of any known internal and surgical disease and complications associated with pregnancy)
Fetus with cephalic presentation
Bishop Cervical Score Less than 4 before the study
Single pregnancy
Index Body mass 19.8 to 30
Estimated fetal weight less than 4000 grams
Healthy amniotic sac (Also lack of oligo and poly hydramnios)
Lack of stenosis of the pelvis
Lack of sex 72 hours before the study
No use of any complementary or traditional method for induction of labor
Lack of uterine contractions
External ear on both sides with no lumps, swelling, infection or wound for auriculotherapy</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Breech presentation
High risk pregnancy such as gestational diabetes, high blood pressure in pregnancy, Previa
Estimated fetal weight over 4000 grams
Bleeding before and during the study
Stripping before starting the study
Decrease fetal movement
Use of any complementary or traditional method for induction of labor
Nipple stimulation during study
Rupture of the amniotic sac before the start of the study
No pressure points in 1full day
Cancellation and dissatisfaction with the mother of auriculotherapy
Request termination of pregnancy by elective cesarean section or pharmaceutical methods</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>080.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Spontaneous vertex delivery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: We randomly place 70 regnant women in the intervention and placebo groups. For each individual intervention group explained that  auriculotherapy  from 39 weeks to 40 weeks of pregnancy once done. If the cervix is unprepared and the labor pains do not begin 72 hours after the intervention, auriculotherapy is performed again. In the intervention group, before auriculotherapy to determine the Bishop score, vaginal exam as well as uterine contractions and fetal heart checked. For the preparation of cervix and the onset of  labour, 11 points are stimulated: Shen Men, master shoulder , thalamic, Hypothalamus, prostaglandin, anterior pituitary, posterior pituitary, endocrine, (2) uterine, lumbar and lung. After disinfection of the ear with 75% alcohol and one minute of general massage for relaxation, electrical stimulation was performed with a Pointer Excel 2 (Made in China) device with a frequency of 2–4 Hz and a current intensity of 2–4 mA, each point is stimulated by the researcher for 15 seconds. . Finally, 5 points of left ear including endocrine, posterior pituitary, prostaglandin and uterus (2 points) and 5 points of right ear including Shen Men ,thalamic, master shoulder ,lung, lumbar are placed one vacaria seed. The mother is instructed to push each point up to 72 hours every hour for 1 minute. Seed pressure should be enough power to cause pain and irritation of the outer ear.They may also experience different sensations when seed  pressure, such as numbness, swelling, mild pain or heat. It should be noted that during sleep and rest for 8 hours do not need to squeeze. To prevent forgetfulness, the researcher remembers pressing the points by phone, asking for possible problems and complications.</i_keyword>
      <i_keyword>Placebo group: The placebo group will consist of 35 pregnant women who are eligible for the study. In this group, the outer ear is cleaned with 75% alcohol and then several points from the same points in the intervention group are massaged with the silent machine so that the stimulation is not triggered. It is then placed on the 3 points of the left ear including the thalamic, Shen Men, lung and the 3 points of the right ear including the posterior pituitary, prostaglandin and the uterus of a seed without vakaria. The pregnant mother is told not to push the points at all.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cervical ripening. Timepoint: Before intervention, 72 and 144 hours after intervention and hospitalization time. Method of measurement: Vaginal examination.</prim_outcome>
      <prim_outcome>Initiation labour. Timepoint: Before intervention, 72 and 144 hours after intervention and hospitalization time. Method of measurement: examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The length of the first stage of labor. Timepoint: The end of the study. Method of measurement: Researcher-made questionnaire.</sec_outcome>
      <sec_outcome>The length of the second stage of labor. Timepoint: The end of the study. Method of measurement: Researcher-made questionnaire.</sec_outcome>
      <sec_outcome>Baby Apgar. Timepoint: The end of the study. Method of measurement: Researcher-made questionnaire.</sec_outcome>
      <sec_outcome>Type of delivery. Timepoint: The end of the study. Method of measurement: Researcher-made questionnaire.</sec_outcome>
      <sec_outcome>Use of Oxytocin. Timepoint: The end of the study. Method of measurement: Researcher-made questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-02-02</approval_date>
        <contact_name>Organizational Ethics Committee for Research in School of Nursing and Midwifery and School of Rehabi</contact_name>
        <contact_address>Tehran University of Medical Sciences, Tehran, Tohid Square, Dr. Mirkhani St. (East Nursing) Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
